Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Patient characteristics and early experiences with anti-obesity medications: the CAMP study
Tewksbury C, Soliva EA, Scheffey K, et al.
Frontiers in nutrition, 2026;13:1931188
The effects of tirzepatide and semaglutide on clinical and metabolic outcomes in patients with heart failure with preserved ejection fraction and obesity: a systematic review and meta-analysis
AlAraibi AJ, Shakeeb FN, Alqatta T, et al.
Nutrition, metabolism, and cardiovascular diseases : NMCD, 2026;:104994
Dorsomedial striatal GABA dynamics organize palatable reward consumption and are reshaped by GLP-1 receptor agonism
Copling AN, Dinckol O, Wenger NH, et al.
bioRxiv : the preprint server for biology, 2026
Advances in pharmacologic management of obesity: oral semaglutide for weight management
Zainab F, Hasan AH
Annals of medicine and surgery (2012), 2026;88(10):6244-6248
Off-label semaglutide: A call for monitoring protocols in non-obese populations
Rehman M
JPMA. The Journal of the Pakistan Medical Association;76(8):1402
Screening for Metabolic Dysfunction-Associated Steatohepatitis in Adults with Type 2 Diabetes in the U.S. and 5 European Countries: A Cost-Utility Analysis
Noureddin M, Jones C, Schattenberg JM, et al.
JHEP reports : innovation in hepatology, 2026;:102018
Association of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study
Hung CT, An CY, Suk CW, et al.
Journal of asthma and allergy, 2026;19:637738
GLP-1 receptor agonists and ocular safety- Pharmacokinetic insights into ischemic optic neuropathy and diabetic retinopathy risk: A review
Malluhi M, Al-Naemi A, Akhtar S
Biomolecules & biomedicine, 2026
Case Report: Acute biliary pancreatitis after semaglutide dose escalation in an adolescent with obesity and cholelithiasis
Alanizi AH, Alruwythi GM, Alotaibi NH, et al.
Frontiers in pediatrics, 2026;14:1959617
Advances in the management of obesity: non-pharmacological strategies, herbal formulations, current pharmacotherapy, emerging drugs, and future perspectives
Mehetre KN, Dawane JS
Frontiers in endocrinology, 2026;17:1933913
Semaglutide and pioglitazone restore airway mucosal homeostasis by resolving Pseudomonas aeruginosa pyocyanin-induced mucus hypersecretion, ciliostasis, and type 2 airway inflammation
Wu C, Kulkarni NA, Lew SQ, et al.
Frontiers in immunology, 2026;17:1877061
GLP-1 Receptor Agonists and Reproductive Health: Implications for Contraception, Fertility, and Pregnancy
Porterfield F, Mulligan J, Salim K, et al.
Endocrinology and metabolism clinics of North America, 2026;55(4):637-648
Single or multiple nutritional hormone receptor modulators for chronic kidney disease
Heerspink HJL
Clinical kidney journal, 2026;19(Suppl 1):i26-i35
Case report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome
Li S, Yu J, Wei J, et al.
Medicine;105(36):e50605
Improvement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist
Blitshteyn S, Schofield JR, Haire N, et al.
Immunopharmacology and immunotoxicology, 2026;:1-6
HIF-1 exerts a double-edged sword regulatory role in hippocampal neuronal PANoptosis of Alzheimer’s disease through HK2/VDAC1/NLRP3 axis and RIPK3 signal
Wang S, Luo L, Jiang X, et al.
Pharmacological research, 2026;:108440
A Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy
Ampofo E, Apprey C, Amoako M, et al.
Obesity science & practice, 2026;12(5):e70188
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Liu H, Zhang M, Tacke F
Drug design, development and therapy, 2026;20:543657
Metformin-Associated Lactic Acidosis and Relative Euglycemic Ketoacidosis Precipitated by a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report and Literature Review
Adnani H, Ladiwala Z, Lee M, et al.
Kidney360, 2026
Oral Incretin-Based Therapies for Weight Management
Cheng HE, Bonafede M, Shukla AP
Current atherosclerosis reports, 2026;28(1)